RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
Immunosuppressive drugs at the initial phase of sepsis: practical issues. https://t.co/AjBaHGG0Fm https://t.co/cTxz7xFfd3
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
RT @drtimothyli: Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft reject…
Management of immunosuppressants of solid organ transplant (SOT) recipients during sepsis ➡️Risk assessment: graft rejection vs sepsis progression ➡️Withhold MMF/mTOR inhibitors before calcineurin inhibitors if needed ➡️Watch out for drug interactions ht
RT @yourICM: Infections in solid organ #transplant recipients 🧫 epidemiology & risk assessment 🧫 prophylaxis 🧫 acute respiratory failure 🧫…
RT @yourICM: Infections in solid organ #transplant recipients 🧫 epidemiology & risk assessment 🧫 prophylaxis 🧫 acute respiratory failure 🧫…
@NCICancer @ASIDANZ @the_shpa
RT @yourICM: Infections in solid organ #transplant recipients 🧫 epidemiology & risk assessment 🧫 prophylaxis 🧫 acute respiratory failure 🧫…
RT @FOAMecmo: Diagnostic & therapeutic approach to infections in solid organ #transplantation ⏲️early: mainly postop/nosocomial ⏲️intermedi…
RT @FOAMecmo: Diagnostic & therapeutic approach to infections in solid organ #transplantation ⏲️early: mainly postop/nosocomial ⏲️intermedi…
RT @yourICM: Infections in solid organ #transplant recipients 🧫 epidemiology & risk assessment 🧫 prophylaxis 🧫 acute respiratory failure 🧫…
RT @yourICM: Infections in solid organ #transplant recipients 🧫 epidemiology & risk assessment 🧫 prophylaxis 🧫 acute respiratory failure 🧫…
RT @FOAMecmo: Diagnostic & therapeutic approach to infections in solid organ #transplantation ⏲️early: mainly postop/nosocomial ⏲️intermedi…
RT @yourICM: Infections in solid organ #transplant recipients 🧫 epidemiology & risk assessment 🧫 prophylaxis 🧫 acute respiratory failure 🧫…
RT @yourICM: Infections in solid organ #transplant recipients 🧫 epidemiology & risk assessment 🧫 prophylaxis 🧫 acute respiratory failure 🧫…
RT @yourICM: Infections in solid organ #transplant recipients 🧫 epidemiology & risk assessment 🧫 prophylaxis 🧫 acute respiratory failure 🧫…
RT @yourICM: Infections in solid organ #transplant recipients 🧫 epidemiology & risk assessment 🧫 prophylaxis 🧫 acute respiratory failure 🧫…
RT @FOAMecmo: Diagnostic & therapeutic approach to infections in solid organ #transplantation ⏲️early: mainly postop/nosocomial ⏲️intermedi…
RT @yourICM: Infections in solid organ #transplant recipients 🧫 epidemiology & risk assessment 🧫 prophylaxis 🧫 acute respiratory failure 🧫…
RT @yourICM: Infections in solid organ #transplant recipients 🧫 epidemiology & risk assessment 🧫 prophylaxis 🧫 acute respiratory failure 🧫…
RT @FOAMecmo: Diagnostic & therapeutic approach to infections in solid organ #transplantation ⏲️early: mainly postop/nosocomial ⏲️intermedi…
RT @yourICM: Infections in solid organ #transplant recipients 🧫 epidemiology & risk assessment 🧫 prophylaxis 🧫 acute respiratory failure 🧫…
RT @yourICM: Infections in solid organ #transplant recipients 🧫 epidemiology & risk assessment 🧫 prophylaxis 🧫 acute respiratory failure 🧫…
RT @FOAMecmo: Diagnostic & therapeutic approach to infections in solid organ #transplantation ⏲️early: mainly postop/nosocomial ⏲️intermedi…
RT @FOAMecmo: Diagnostic & therapeutic approach to infections in solid organ #transplantation ⏲️early: mainly postop/nosocomial ⏲️intermedi…
RT @yourICM: Infections in solid organ #transplant recipients 🧫 epidemiology & risk assessment 🧫 prophylaxis 🧫 acute respiratory failure 🧫…
RT @yourICM: Infections in solid organ #transplant recipients 🧫 epidemiology & risk assessment 🧫 prophylaxis 🧫 acute respiratory failure 🧫…
RT @yourICM: Infections in solid organ #transplant recipients 🧫 epidemiology & risk assessment 🧫 prophylaxis 🧫 acute respiratory failure 🧫…
RT @yourICM: Infections in solid organ #transplant recipients 🧫 epidemiology & risk assessment 🧫 prophylaxis 🧫 acute respiratory failure 🧫…
RT @yourICM: Infections in solid organ #transplant recipients 🧫 epidemiology & risk assessment 🧫 prophylaxis 🧫 acute respiratory failure 🧫…
RT @yourICM: Infections in solid organ #transplant recipients 🧫 epidemiology & risk assessment 🧫 prophylaxis 🧫 acute respiratory failure 🧫…
RT @yourICM: Infections in solid organ #transplant recipients 🧫 epidemiology & risk assessment 🧫 prophylaxis 🧫 acute respiratory failure 🧫…